Description: Zytiga is an oral medication indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC). It is often prescribed in combination with other medications, such as prednisone or prednisolone.

Composition: The active ingredient in Zytiga is Abiraterone.

Uses: Zytiga is used in the treatment of metastatic castration-resistant prostate cancer (mCRPC), which is prostate cancer that has spread to other parts of the body and is no longer responsive to hormone therapy.

How to Use: Zytiga is taken orally as a tablet, usually once daily on an empty stomach, at least one hour before or two hours after a meal. It is typically taken in combination with low-dose corticosteroids, such as prednisone or prednisolone.

Dosage: The dosage of Zytiga can vary depending on individual patient factors and the specific treatment regimen prescribed by the healthcare provider. It is important to follow the prescribed dosage and administration instructions.

Storage Conditions: Zytiga should be stored according to the manufacturer’s instructions, typically at room temperature away from moisture and heat.

Mechanism of Action: Abiraterone works by inhibiting the production of androgens (male hormones) in the body, including testosterone, which can fuel the growth of prostate cancer cells.

Precautions:

• Zytiga may cause adrenal insufficiency, so patients should be monitored for symptoms such as fatigue, weakness, and low blood pressure.
• It may also cause liver toxicity, so liver function should be monitored regularly during treatment.

Contraindications: Zytiga may be contraindicated in patients with a known hypersensitivity to Abiraterone or any of its components. It should not be used in women, especially pregnant or breastfeeding women, due to the risk of harm to the fetus or infant.

Interactions: Zytiga may interact with other medications, including certain drugs that are metabolized by the liver. It is important to inform the healthcare provider about all medications, supplements, and herbal products being taken.

Overdose: In case of a suspected overdose, seek immediate medical attention. Overdose symptoms may include nausea, vomiting, fatigue, and electrolyte abnormalities.

Side Effects: Common side effects of Zytiga may include fatigue, hypertension, fluid retention, joint swelling or pain, hot flashes, and gastrointestinal symptoms such as diarrhea or nausea. Serious side effects can occur, and patients should promptly report any unusual or severe symptoms to their healthcare provider.

Always consult with a healthcare professional for the most accurate and personalized information regarding the use of Zytiga (Abiraterone) or any other medication.